Evidence map›Paper›PMID 27677866›Full record

ArticleDrug delivery and translational research2017

Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.

Venkata Ramana Malipeddi, Rajendra Awasthi, Daniela Dal Molim Ghisleni, Marina de Souza Braga, Irene Satiko Kikuchi, Terezinha de Jesus Andreoli Pinto, Kamal Dua

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Pharmaceutics · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pharmacokinetic and Pharmacodynamics of Self-Assembled Cubic Liquid Crystalline Nanoparticle Gel After Transdermal Administration.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Venkata Ramana MalipeddiAmity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, 226028, India. mvramana@lko.amity.edu.
Rajendra AwasthiLaureate Institute of Pharmacy, Jawalamukhi, Kangra, Himachal Pradesh, 176031, India.ORCID 0000-0002-1286-1874
Daniela Dal Molim GhisleniDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Rua Professor Lineu Prestes, São Paulo, 05508-000, Brazil.
Marina de Souza BragaDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Rua Professor Lineu Prestes, São Paulo, 05508-000, Brazil.
Irene Satiko KikuchiDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Rua Professor Lineu Prestes, São Paulo, 05508-000, Brazil.
Terezinha de Jesus Andreoli PintoDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Rua Professor Lineu Prestes, São Paulo, 05508-000, Brazil.
Kamal DuaSchool of Pharmacy and Biomedical Sciences, The University of Newcastle, Callaghan, Newcastle, NSW, 2308, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to develop matrix-type transdermal drug delivery system (TDDS) of metoprolol tartrate using polyvinyl pyrrolidone (PVP) and polyvinyl alcohol (PVA). The transdermal films were evaluated for physical parameters, Fourier transform infrared spectroscopy analysis (FTIR), differential scanning calorimetry (DSC), in vitro drug release, in vitro skin permeability, skin irritation test and stability studies. The films were found to be tough, non-sticky, easily moldable and possess good tensile strength. As the concentration of PVA was increased, the tensile strength of the films was also increased. Results of FTIR spectroscopy and DSC revealed the absence of any drug-polymer interactions. In vitro release of metoprolol followed zero-order kinetics and the mechanism of release was found to be diffusion rate controlled. In vitro release studies of metoprolol using Keshary-Chein (vertical diffusion cell) indicated 65.5 % drug was released in 24 h. In vitro skin permeation of metoprolol transdermal films showed 58.13 % of the drug was released after 24 h. In vitro skin permeation of metoprolol followed zero-order kinetics in selected formulations. The mechanism of release was found to be diffusion rate controlled. In a 22-day skin irritation test, tested formulation of transdermal films did not exhibit any allergic reactions, inflammation, or contact dermatitis. The transdermal films showed good stability in the 180-day stability study. It can be concluded that the TDDS of MPT can help in bypassing the first-pass effect and will provide patient improved compliance, without sacrificing the therapeutic advantages of the drugs.

Indexed as

Drug Delivery SystemsAdministration, CutaneousAnimalsAntihypertensive AgentsCalorimetry, Differential ScanningDrug LiberationDrug StabilityIn Vitro TechniquesMetoprololPolyvinyl AlcoholPovidoneRatsSkinSkin AbsorptionSkin Irritancy TestsSpectroscopy, Fourier Transform InfraredAntihypertensive AgentsMetoprololPolyvinyl AlcoholPovidoneMetoprolol tartratePolyvinyl alcoholPolyvinyl pyrrolidoneSkin permeation testTransdermal drug deliveryTransdermal film

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.